Skip to main content
. 2021 Feb 8;11(2):238. doi: 10.3390/biom11020238

Table 2.

The applications of nanobodies in advanced CAR-T therapies.

Target CAR Structure Reference
Spacer Transmembrane Costimulatory Signaling New Function
MUC1 IgG3-Fc&Hinge-Hinge CD28 CD28-OX40 CD3ζ iCaspase 8 [66]
EGFR Anti-E5B9-CD28 CD28 CD28 CD3ζ UniCAR [103]
Anti-E5B9-CD28 CD28 CD28 CD3ζ UNiCAR & Bivalent VHH [104]
CD20&HER2 IgG1-Fc CD28 CD28 CD3ζ Bispecific [105]
PD-L1 CD8α CD8α CD28 CD3ζ secrete anti-CD47 [106]
CD8α CD8α CD28 CD3ζ secrete anti-CD47-Fc
CD8α CD8α CD28 CD3ζ secrete anti-CTLA4-Fc& anti-CD47
EIIIB CD8α CD8α CD28 CD3ζ secrete anti-PD-L1
CD8α CD8α CD28 CD3ζ secrete anti-CD47
CD8α CD8α CD28 CD3ζ secrete anti-CTLA4-Fc